PUMA BIOTECHNOLOGY INC
Symbol: PBYI (NASDAQ)
4.54
▼ (-3.72%) -0.175
Company Description:
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
Key Stats
- Today's Open: $4.65
- Today's High: $4.725
- Today's Low: $4.505
- Today's Volume: 375.39K
- Yesterday Close: $4.71
- Yesterday High: $4.74
- Yesterday Low: $4.57
- Yesterday Volume: 448.93K
- Last Min Volume: 4.48K
- Last Min High: $4.535
- Last Min Low: $4.535
- Last Min VWAP: $4.535
Company Profile
- Name: PUMA BIOTECHNOLOGY INC
- Website: https://www.pumabiotechnology.com
- Listed Date: 2012-03-21
- Location: LOS ANGELES, CA
- Market Status: Active
- CIK Number: 0001401667
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $229.69M
- Round Lot: 100
- Outstanding Shares: 50.37M
- Asset Type: CS
RECENT FILINGS FOR PBYI
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-07 | 10-Q | View |
| 2025-08-07 | 8-K | View |
| 2025-08-07 | 10-Q/A | View |
| 2025-07-22 | 4 | View |
| 2025-07-18 | 144 | View |
| 2025-07-10 | 4 | View |
| 2025-07-10 | 4 | View |
| 2025-07-10 | 4 | View |
| 2025-07-09 | 144 | View |
| 2025-07-09 | 144 | View |
| 2025-07-09 | 144 | View |
| 2025-07-08 | 144 | View |
| 2025-07-08 | 144 | View |
| 2025-07-08 | 144 | View |
| 2025-06-24 | 8-K | View |
| 2025-06-17 | 4 | View |
| 2025-06-17 | 4 | View |
| 2025-06-17 | 4 | View |
| 2025-06-17 | 4 | View |
| 2025-06-17 | 4 | View |
Latest News on PBYI